TTNP - TITAN PHARMACEUTICALS INC
4.61
-0.180 -3.905%
Share volume: 3,358,220
Last Updated: 10-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.79
-0.18
-0.04%
Summary score
41%
Profitability
25%
Dept financing
38%
Liquidity
49%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.54%
Return on assets
-25.05%
Return on sales
0%
Return on invested capital
182.54%
Total debt ratio
34.32%
Debt ratio change over timeo
0%
Current Ratio
4.65%
Quick Ratio
0%
Cash Position Ratio
4.1%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-48.89%
Return on assets
-28.53%
Return on sales
0%
Return on invested capital
217%
Total debt ratio
34.11%
Debt ratio change over timeo
0%
Current Ratio
4.97%
Quick Ratio
0%
Cash Position Ratio
4.52%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-103.79%
Return on assets
-31.95%
Return on sales
0%
Return on invested capital
325.39%
Total debt ratio
68.3%
Debt ratio change over time
0%
Current Ratio
6.11%
Quick Ratio
0%
Cash Position Ratio
5.93%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TTNP | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -42.54% | 6.52% | 16.07% | 8% |
| Return on assets | -25.05% | 3.2% | 7.46% | 5.12% |
| Return on sales | 0% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | 182.54% | 9.05% | 13.06% | 8.23% |
| Profitability | 25% | 41% | 77% | 49% |
| Total debt ratio | 34.32% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 38% | 23% | 25% | 18% |
| Current Ratio | 4.97% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 4.52% | 0.33% | 1.09% | 0.45% |
| Liquididy | 49% | 52% | 33% | 28% |
| Short-term ratios | TTNP | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -48.89% | 6.57% | 13.54% | 7.21% |
| Return on assets | -28.53% | 3.23% | 6.63% | 5.05% |
| Return on sales | 0% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | 217% | 9.41% | 12.01% | 7.62% |
| Profitability | 25% | 45% | 76% | 51% |
| Total debt ratio | 34.11% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 38% | 24% | 25% | 18% |
| Current Ratio | 4.97% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 4.52% | 0.33% | 1.09% | 0.45% |
| Liquididy | 49% | 52% | 35% | 24% |